Highbridge Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Highbridge Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,600	Closed	-$365K	–	519
2018 Q2	$365K	Buy	+6,600	New	+$356K	0.01%	657
2016 Q4	–	Sell	-6,900	Closed	-$374K	–	1264
2016 Q3	$374K	Buy	+6,900	New	+$443K	0.01%	915
2014 Q3	–	Sell	-32,200	Closed	-$1.56M	–	1212
2014 Q2	$1.56M	Buy	+32,200	New	+$1.59M	0.02%	465
2014 Q1	–	Sell	-5,000	Closed	-$266K	–	1047
2013 Q4	$266K	Sell	5,000 -52,000	-91%	-$2.65M	﹤0.01%	884
2013 Q3	$2.64M	Buy	+57,000	New	+$2.5M	0.03%	453

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Highbridge Capital Management's BMY Position: Q4 2018 in Review

Highbridge Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 30,734 shares — an estimated $1.91M sold.

Highbridge Capital Management first reported a position in BMY in Q2 2013 and held it in 13 quarters. The position peaked at $22.7M in Q1 2017. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Highbridge Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 30,734 Bristol-Myers Squibb shares in Q4 2018, an estimated $1.91M.
Highbridge Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 13 quarters.
Highbridge Capital Management's Bristol-Myers Squibb position peaked at $22.7M in Q1 2017.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.